Dr. Sam Peyvand Most, MD

Dr. Most practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Most's NPI, 1396795696, was assigned on May 10, 2006. Dr. Most graduated from Stanford University School Of Medicine in 1995. Dr. Most holds California license A88795.

Dr. Most's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Most's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Most to 1 more hospital, named with a free account. Dr. Most's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Most practices, 2 sites in all. Vendor and product names are available with a free account.

Facial plastic surgery is Dr. Most's primary specialty in the NPI Registry, under taxonomy code 207YS0123X. Dr. Most is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Most is licensed in California.

CMS data shows 166 Medicare services from Dr. Most across 6 procedure codes in 2024, for 92 Medicare patients. Medicare paid $36,835 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 92 Medicare patients who saw Dr. Most in 2024. The largest group is 65 to 74, with 47 patients. 65% of them have high cholesterol, and 55% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Most's median patient age at 45, with 57% women.

In 2018, Dr. Most wrote 28 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $109 in total drug cost. In 2017, CMS named 28 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Most for performance year 2024, reported as part of a group. Dr. Most accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 55 procedures of melanoma (skin cancer) excision by Dr. Most, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 171 papers to Dr. Most, published from 2010 to 2025. 2020 was the busiest year, with 16. The most frequent topics are Rhinoplasty, Nose and Esthetics. Dr. Most has published most often in JAMA Facial Plast Surg. Dr. Most's most frequent co-authors are Priyesh Patel, Emily Anne Spataro, MD and Jose Enrique Barrera, FACS, MD.

Dmand AI links Dr. Most to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Pain, Postoperative and Postoperative Complications. Stanford University sponsors the most, 2.

CMS Open Payments shows 37 general payments to Dr. Most from 12 drug and device companies from 2016 to 2025. Gifts make up the largest share, 58% of the total. Stryker Corporation paid the most, $64,655.

Dmand AI lists 5 awards for Dr. Most, most recently Vice President for Research and Development in 2017.

Dr. Most graduated from Stanford University School Of Medicine in 1995. Dr. Most is a member of NHS.

Dr. Most is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.